Cargando…

Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic

BACKGROUND AND AIMS: Patients with liver cirrhosis (LC) are considered to be at increased risk for mortality when acquiring SARS-CoV-2 infection and subsequently developing Corona Virus Disease 2019 (COVID-19). During the COVID-19 pandemic, hospitals are regarded as sites with increased risk of infe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fründt, Thorben, Kuballa, Lilith, Lütgehetman, Marc, Nörz, Dominik, Arend, Hannes, Brehm, Thomas T., Schulze zur Wiesch, Julian, Horvatits, Thomas, Horvatits, Karoline, Huber, Samuel, Wege, Henning, Kluwe, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699616/ https://www.ncbi.nlm.nih.gov/pubmed/34941875 http://dx.doi.org/10.1371/journal.pone.0258450

Ejemplares similares

The Clinical Perspective on Hepatitis E
por: Horvatits, Thomas, et al.
Publicado: (2019)

Lower Levels of Transaminases but Higher Levels of Serum Creatinine in Patients with Acute Hepatitis E in Comparison to Patients with Hepatitis A
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity
por: Drolz, Andreas, et al.
Publicado: (2021)

Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV Infection
por: Horvatits, Thomas, et al.
Publicado: (2020)

Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial
por: Wehmeyer, Malte H., et al.
Publicado: (2022)

Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients
por: Fründt, Thorben, et al.
Publicado: (2021)

Muscle quality determined by computed tomography predicts short-term and long-term survival after liver transplantation
por: Molwitz, Isabel, et al.
Publicado: (2023)

Disseminated intravascular coagulation score predicts mortality in critically ill patients with liver cirrhosis
por: Drolz, A, et al.
Publicado: (2015)

Epidemiology and outcome of cardiac arrest in patients with liver cirrhosis
por: Roedl, K, et al.
Publicado: (2015)

Outcome of in- and out-of-hospital cardiac arrest survivors with liver cirrhosis
por: Roedl, Kevin, et al.
Publicado: (2017)

Extrahepatic manifestations and HEV, the genotype matters
por: Horvatits, Thomas, et al.
Publicado: (2018)

Increased Expression of Complement Regulators CD55 and CD59 on Peripheral Blood Cells in Patients with EAHEC O104:H4 Infection
por: Dammermann, Werner, et al.
Publicado: (2013)

Equal Efficacy and Safety Profile in Elderly Patients with Hepatocellular Carcinoma Receiving Palliative Treatment
por: Fründt, Thorben W., et al.
Publicado: (2022)

Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinoma
por: Fründt, Thorben, et al.
Publicado: (2022)

Comparison of the integrin α4β7 expression pattern of memory T cell subsets in HIV infection and ulcerative colitis
por: Wittner, Melanie, et al.
Publicado: (2019)

Acid–base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease
por: Drolz, Andreas, et al.
Publicado: (2018)

Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General
por: Pischke, Sven, et al.
Publicado: (2021)

Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients
por: Gömer, André, et al.
Publicado: (2023)

Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022
por: Nörz, Dominik, et al.
Publicado: (2022)

Akutes Leberversagen: Zeitgerechte Diagnose und Therapie ist entscheidend für die Prognose
por: Rutter, Karoline, et al.
Publicado: (2018)

Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort Study
por: Woo, Marcel S., et al.
Publicado: (2022)

Anti-HEV seroprevalence and rate of viremia in a German cohort of dogs, cats, and horses
por: Pischke, S., et al.
Publicado: (2023)

Author Correction: Anti-HEV seroprevalence and rate of viremia in a German cohort of dogs, cats, and horses
por: Pischke, S., et al.
Publicado: (2023)

Prognostic impact of ICG-PDR in patients with hypoxic hepatitis
por: Horvatits, Thomas, et al.
Publicado: (2015)

Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

Frequent detection of functional hyposplenism via assessment of pitted erythrocytes in patients with advanced liver cirrhosis
por: Wehmeyer, Malte H., et al.
Publicado: (2022)

Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Higher Risk of HEV Transmission and Exposure among Blood Donors in Europe and Asia in Comparison to North America: A Meta-Analysis
por: Wolski, Annika, et al.
Publicado: (2023)

Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit
por: Drolz, Andreas, et al.
Publicado: (2016)

Microplastics detected in cirrhotic liver tissue
por: Horvatits, Thomas, et al.
Publicado: (2022)

Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival
por: Piecha, Felix, et al.
Publicado: (2019)

The NTPase/helicase domain of hepatitis C virus nonstructural protein 3 inhibits protein kinase C independently of its NTPase activity
por: Hartjen, Philip, et al.
Publicado: (2013)

Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients
por: Brehm, Thomas Theo, et al.
Publicado: (2019)

Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients
por: Pflüger, Lisa Sophie, et al.
Publicado: (2020)

SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients
por: Ruether, Darius F., et al.
Publicado: (2022)

High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities
por: Bockmann, Jan-Hendrik, et al.
Publicado: (2021)

Liver Cirrhosis as a Risk Factor for Direct-Acting Antiviral Therapy Failure in Real-Life Hepatitis C Virus/Human Immunodeficiency Virus Coinfection
por: Boesecke, Christoph, et al.
Publicado: (2017)

Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system
por: Pflüger, Lisa Sophie, et al.
Publicado: (2021)

Akutes Leberversagen
por: Rutter, K., et al.
Publicado: (2016)

Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u8rtggqn3s0v3r2jb4ornsgn14